Kewaunee Scientific GAAP EPS of -$0.09, revenue of $54.56M

• Kewaunee Scientific press release (NASDAQ:KEQU): FQ2 GAAP EPS of -$0.09.
• Revenue of $54.56M (+39.8% Y/Y).
• EBITDA for the quarter was $1.25M compared to -$2.12M for the prior year period.
• The company's order backlog was $157.8M on October 31, 2022, as compared to $139.7M on October 31, 2021, and $173.9M on April 30, 2022.